| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 63-45-6 | 磷酸伯安喹; N4-(6-甲氧基-8-喹啉基)-1-戊二胺二磷酸盐 | Primaquine diphosphate; Primaquine bisphosphate; 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline diphosphate | ![]() | C15H21N3O.2(H3PO4) | 详情 | 供应商 |
| 90-34-6 | 伯氨喹; N-(6-甲氧基喹啉-8-基)戊-1,4-二胺 | Primaquine; 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline; N-(6-Methoxyquinolin-8-yl)pentane-1,4-diamine | ![]() | C15H21N3O | 详情 | 供应商 |
| 143664-11-3 | 依克立达; N-[4-[2-(6,7-二甲氧基-3,4-二氢-1H-异喹啉-2-基)乙基]苯基]-5-甲氧基-9-氧代-10H-吖啶-4-甲酰胺 | Elacridar; N-[4-[2-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide | ![]() | C34H33N3O5 | 详情 | 供应商 |
| 698387-09-6 | (2E)-N-[4-[[3-氯-4-[(吡啶-2-基)甲氧基]苯基]氨基]-3-氰基-7-乙氧基喹啉-6-基]-4-(二甲基氨基)丁-2-烯酰胺 | Neratinib; (2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide | ![]() | C30H29ClN6O3 | 详情 | 供应商 |
| 109628-27-5 | N-(6-甲氧基-8-喹啉基)对甲苯磺酰胺 | Benzenesulfonamide,N-(6-methoxy-8-quinolinyl)-4-methyl-; p-Toluenesulfonamide,N-(6-methoxy-8-quinolyl)- (5CI); NSC 120213; TSQ | ![]() | C17H16N2O3S | 详情 | 供应商 |
| 849217-64-7 | N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺; N- | GSK 1363089; Foretinib; GSK 1363089; EXEL-2880; XL880; N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL880(GSK1363089) | 无 | C34H34F2N4O6 | 详情 | 供应商 |
| 849217-68-1 | CABOZANTINIB; N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺 | N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; Cabozantinib; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL184; Cabozantinib(XL184) | ![]() | C28H24FN3O5 | 详情 | 供应商 |
| 190728-25-7 | 4-[(6,7-二甲氧基-4-喹啉)氧基]苯胺 | Benzenamine, 4-[(6,7-dimethoxy-4-quinolinyl)oxy]- | 无 | C17H16N2O3 | 详情 | 供应商 |
| 417721-36-9 | 4-氯-7-甲氧基喹啉-6-酰胺; 4-氯-7-甲氧基喹啉-6-酰胺; 4-氯-7-甲氧基喹啉-6-甲酰胺 | 4-chloro-7-Methoxyquinoline-6-carboxaMide; 4-chloro-7-Methoxyquinoline-6-carboxaMide; 4-chloro-7-Methoxy-6-QuinolinecarboxaMide | ![]() | C11H9ClN2O2 | 详情 | 供应商 |
| 630420-16-5 | (1R,2S)-N-[(1,1-二甲基乙氧基)羰基]-3-甲基-L-缬氨酰-(4R)-4-[(7-氯-4-甲氧基-1-异喹啉基)氧基]-L-脯氨酰-1-氨基-N-(环丙基磺酰基)-2-乙烯基环丙基甲酰胺; (1R,2S)-N-[(1,1-二甲基乙氧基)羰基]-3-甲基-L-缬氨酰-(4R)-4-[(7-氯-4-甲氧基-1-异喹啉基)氧基]-L-脯氨酰-1-氨基-N-(环丙基磺酰基)-2-乙烯基环丙基甲酰胺; 阿那匹韦 | (1R,2S)-N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide; (1R,2S)-N-[(1,1-Dimethylethoxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide; Asunaprevir; BMS 650032; Asunaprevir (BMS-650032); BMS 650032/Asunaprevir | ![]() | C35H46ClN5O9S | 详情 | 供应商 |
| 913376-83-7 | AMG458; 1-(2-羟基-2-甲基丙基)-N-[5-[(7-甲氧基喹啉-4-基)氧基]吡啶-2-基]-5-甲基-3-氧代-2-苯基-2,3-二氢-1H-吡唑-4-甲酰胺 | AMG 458; AMG 458; 1-(2-Hydroxy-2-methylpropyl)-N-[5-[(7-methoxyquinolin-4-yl)oxy]pyridin-2-yl]-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide | 无 | C30H29N5O5 | 详情 | 供应商 |
| 343787-29-1 | 1-[2-[5-(2-甲氧基乙氧基)苯并咪唑-1-基]喹啉-8-基]哌啶-4-基胺; 1-[2-[5-(2-甲氧基乙氧基)苯并咪唑-1-基]喹啉-8-基]哌啶-4-基胺 | 1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine; 1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine; CP 673451; 1-[2-[5-(2-Methoxyethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-ylamine | ![]() | C24H27N5O2 | 详情 | 供应商 |
| 1140909-48-3 | N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺 (S)-苹果酸盐; CABOZANTINIB (S)-苹果酸盐; N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺 (S)-苹果酸盐; CABOZANTINIB MALATE; 卡博替尼苹果酸盐; 苹果酸卡博替尼; L-苹果酸卡博替尼 | (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); Cabozantinib (S)-malate; Cabozantinib L-Malate Salt; N-[4-[(6,7-DiMethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxaMide (2S)-; Cabozantinib (S)-Malate(XL-184); Cabozantinib L-Malate | ![]() | C32H30FN3O10 | 详情 | 供应商 |
| 1058137-23-7 | E 3810; 6-[[7-[(1-氨基环丙基)甲氧基]-6-甲氧基-4-喹啉基]氧基]-N-甲基-1-萘甲酰胺 | E-3810; E-3810; 6-[[7-[(1-Aminocyclopropyl)methoxy]-6-methoxy-4-quinolinyl]oxy]-N-methyl-1-naphthalenecarboxamide | 无 | C26H25N3O4 | 详情 | 供应商 |